Each year, readers of the prestigious magazine Condé Nast Traveler vote for their favorite destinations, as well as hotels, resorts, islands, cruises, airlines, and airports, highlighting the best of each category that guides many travelers in the world.
It is with great pride that the Puerto Vallarta Tourism Trust informs that this destination, once again, is nominated in the Best City category. Also included are 17 hotels located in Vallarta, which stand out for the excellence of their lodging services.
The voting is simple, an email is registered and a basic profile is completed. Then select the category in which you want to vote, and in the online voting platform, you put the name of the destination or hotel, by selecting it, in the brief survey.
More than 400 thousand readers around the world participate year after year in the survey leaving tens of thousands of comments; This is the 32nd edition of the survey (the first was conducted in 1987).
The magazine is designed for the discerning and frequent experienced travelers with a wide variety of travel experiences and information covering frequent flyer programs, art, fashion, architecture, culture, gastronomy, and shopping in a variety of destinations around the world.
It is a publication for the sophisticated person who travels regularly with a strong interest in leisure activities. It has specialized content for the sophisticated traveler from the latest in hotels, the best tourist destinations in the world, the most innovative restaurants, and exclusive spas, to the most fascinating adventure trips.
The printed circulation of the magazine is 807,873 in the United States; Eight editions a year are published.
The complete results will be in the print and online edition in the month of November.
Voting is open until June 30.
View this post on InstagramTHE POWER OF STEM CELLS & EXOSOMES
Scientists have recently developed advanced protocols harnessing the power of exosomes to create a new class of therapeutics to improve the effectiveness of stem cell therapy. In particular, they have developed new protocols for neurological diseases such as Alzheimer´s, Parkinson´s, Autism and Multiple Sclerosis. Read More